1. ScholarBank@NUS

Alan Prem Kumar

rp02898

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Alan Prem Kumar
Variants
Kumar, A.P.
Kumar, A.
Prem Kumar, A.
Kumar, Alan Prem Rem
 
Main Affiliation
 
Faculty
 
Email
apkumar@nus.edu.sg
 
Other emails
 

Publications

Refined By:
Department:  ou00221
Date Issued:  [2020 TO 2024]

Results 41-51 of 51 (Search time: 0.009 seconds).

Issue DateTitleAuthor(s)
41Aug-2020Role of microRNA/epithelial-to-mesenchymal transition axis in the metastasis of bladder cancerAshrafizadeh, M.; Hushmandi, K.; Hashemi, M.; Akbari, M.E.; Kubatka, P.; Raei, M.; Koklesova, L.; Shahinozzaman, M.; Mohammadinejad, R.; Najafi, M.; Sethi, G. ; Kumar, A.P. ; Zarrabi, A.
4215-Dec-2023SHP2 inhibitors maintain TGFβ signalling through SMURF2 inhibitionLai, Xianning ; Lui, Sarah Kit Leng ; Lam, Hiu Yan ; Adachi, Yuta; Sim, Wen Jing ; Vasilevski, Natali; Armstrong, Nicola J; Bridgeman, Stephanie Claire; Main, Nathan Michael; Tan, Tuan Zea ; Tirnitz-Parker, Janina EE; Thiery, Jean Paul ; Ebi, Hiromichi; Kumar, Alan Prem ; Eichhorn, Pieter Johan Adam 
4318-Feb-2021Small in size, but large in action: Micrornas as potential modulators of pten in breast and lung cancersAbadi, Asal Jalal; Zarrabi, Ali; Gholami, Mohammad Hossein; Mirzaei, Sepideh; Hashemi, Farid; Zabolian, Amirhossein; Entezari, Maliheh; Hushmandi, Kiavash; Ashrafizadeh, Milad; Khan, Haroon; Kumar, Alan Prem 
4416-Mar-2021Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systemsMirzaei, Sepideh; Mahabady, Mahmood Khaksary; Zabolian, Amirhossein; Abbaspour, Alireza; Fallahzadeh, Peyman; Noori, Maedeh; Hashemi, Farid; Hushmandi, Kiavash; Daneshi, Salman; Kumar, Alan Prem ; Aref, Amir Reza; Samarghandian, Saeed; Makvandi, Pooyan; Khan, Haroon; Hamblin, Michael R; Ashrafizadeh, Milad; Zarrabi, Ali
4530-Mar-2021Super-enhancers for RUNX3 are required for cell proliferation in EBV-infected B cell linesHosoi, Hiroki ; Niibori-Nambu, Akiko; Nah, Giselle Sek Suan; Bahirvani, Avinash Govind ; Mok, Michelle Meng Huang ; Sanda, Takaomi ; Kumar, Alan Prem ; Tenen, Daniel G ; Ito, Yoshiaki; Sonoki, Takashi; Osato, Motomi 
462020Targeting akt/mtor in oral cancer: Mechanisms and advances in clinical trialsHarsha, C.; Banik, K.; Ang, H.L.; Girisa, S.; Vikkurthi, R.; Parama, D.; Rana, V.; Shabnam, B.; Khatoon, E.; Kumar, A.P. ; Kunnumakkara, A.B.
471-Dec-2022Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic responseAshrafizadeh, M; Paskeh, MDA; Mirzaei, S; Gholami, MH; Zarrabi, A; Hashemi, F; Hushmandi, K; Hashemi, M; Nabavi, N; Crea, F; Ren, J; Klionsky, DJ; Kumar, AP ; Wang, Y
481-May-2022Targeting Nuclear Receptors in Lung Cancer-Novel Therapeutic ProspectsGangwar, Shailendra Kumar; Kumar, Aviral; Yap, Kenneth Chun-Hong ; Jose, Sandra; Parama, Dey; Sethi, Gautam ; Kumar, Alan Prem ; Kunnumakkara, Ajaikumar B
497-Aug-2020The Art of Remediating Age-Related Cognitive Decline: Art Therapy Enhances Cognition and Increases Cortical Thickness in Mild Cognitive ImpairmentYu, Junhong ; Rawtaer, Iris ; Goh, Lee Gan; Kumar, Alan Prem ; Feng, Lei ; Kua, Ee Heok ; Mahendran, Rathi 
102-Mar-2022The long and short non-coding RNAs modulating EZH2 signaling in cancerMirzaei, Sepideh; Gholami, Mohammad Hossein; Hushmandi, Kiavash; Hshemi, Farid; Zabolian, Amirhossein; Canadas, Israel; Zarrabi, Ali; Nabavi, Noushin; Aref, Amir Reza; Crea, Francesco; Wang, Yuzhuo; Ashrafizadeh, Milad; Kumar, Alan Prem 
1131-Oct-2021Tris(Dibenzylideneacetone)dipalladium(0) (tris dba) abrogates tumor progression in hepatocellular carcinoma and multiple myeloma preclinical models by regulating the stat3 signaling pathwayArora, Loukik; Mohan, Chakrabhavi Dhananjaya; Yang, Min Hee; Rangappa, Shobith; Deivasigamani, Amudha; Kumar, Alan Prem ; Kunnumakkara, Ajaikumar B.; Garg, Manoj; Chinnathambi, Arunachalam; Alharbi, Sulaiman Ali; Alahmadi, Tahani Awad; Rangappa, Kanchugarakoppal S.; Hui, Kam Man ; Sethi, Gautam ; Ahn, Kwang Seok